Route: Health care research, sickness prevention and treatment
cluster question: 096 How can we improve diagnostics, treatment, and vaccines for immunodeficiencies and infectious diseases?
Periodontal disease (PD) remains one of the most prevalent diseases in humans and dogs, imposing significant burdens on public health […]
View the initiativeRoute: Health care research, sickness prevention and treatment
cluster question: 096 How can we improve diagnostics, treatment, and vaccines for immunodeficiencies and infectious diseases?
Infectious diseases pose major health as well as broad societal challenges as exemplified by the current COVID-19 pandemic. Vaccination with […]
View the initiativeRoute: Regenerative medicine: game changer moving to broad areas of application
cluster question: 096 How can we improve diagnostics, treatment, and vaccines for immunodeficiencies and infectious diseases?
In regenerative medicine, scientists and doctors work together to restore tissues that have been damaged by disease. Stem cells, capable […]
View the initiativeRoute: Personalised medicine: the individual at the centre
cluster question: 096 How can we improve diagnostics, treatment, and vaccines for immunodeficiencies and infectious diseases?
Prevention of infectious diseases by immunization is a prerequisite to avoid morbidity and mortality early in life and ensure healthy […]
View the initiativeRoute: Personalised medicine: the individual at the centre
cluster question: 096 How can we improve diagnostics, treatment, and vaccines for immunodeficiencies and infectious diseases?
Sepsis is a life-threatening syndrome caused by a dysregulated response to infection that leads to organ dysfunction. The global burden […]
View the initiativeRoute: Health care research, sickness prevention and treatment
cluster question: 096 How can we improve diagnostics, treatment, and vaccines for immunodeficiencies and infectious diseases?
In EESAT2, we will use advanced biochemical as well as novel ICT technologies to produce new and novel-to-nature antimicrobial peptides […]
View the initiativeRoute: Health care research, sickness prevention and treatment
cluster question: 096 How can we improve diagnostics, treatment, and vaccines for immunodeficiencies and infectious diseases?
Vaccines are one of the most important and cost-effective public health measures, safeguarding millions of people worldwide from illness, disability […]
View the initiativeRoute: Health care research, sickness prevention and treatment
cluster question: 096 How can we improve diagnostics, treatment, and vaccines for immunodeficiencies and infectious diseases?
Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis (TB) that is responsible for the death of 1.5 million people […]
View the initiativeRoute: Health care research, sickness prevention and treatment
cluster question: 096 How can we improve diagnostics, treatment, and vaccines for immunodeficiencies and infectious diseases?
Auto-immune disorders pose a major worldwide issue with rising prevalence. To date, dozens of immune-based therapies have emerged aiming to […]
View the initiative